AU2003247208A1 - Organic acid salt of amlodipine - Google Patents

Organic acid salt of amlodipine

Info

Publication number
AU2003247208A1
AU2003247208A1 AU2003247208A AU2003247208A AU2003247208A1 AU 2003247208 A1 AU2003247208 A1 AU 2003247208A1 AU 2003247208 A AU2003247208 A AU 2003247208A AU 2003247208 A AU2003247208 A AU 2003247208A AU 2003247208 A1 AU2003247208 A1 AU 2003247208A1
Authority
AU
Australia
Prior art keywords
amlodipine
organic acid
acid salt
salt
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003247208A
Inventor
Jun-Hee Cheon
Seong-Hwan Cho
Eun-Ju Jeong
Hae-Tak Jin
Sung-Hak Jung
Yun-Taek Jung
Hyun-Suk Kang
Young-Hoon Kim
Yun-Cheul Kim
Hyuk-Koo Lee
Kwang-Hyeg Lee
Sung-Hak Lee
Dong-Kwon Lim
Choong-Sil Park
Kyung-Mi Park
Kyu-Jeong Yeon
Yong-Sik Youn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Corp filed Critical CJ Corp
Publication of AU2003247208A1 publication Critical patent/AU2003247208A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2003247208A 2002-07-30 2003-07-30 Organic acid salt of amlodipine Abandoned AU2003247208A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020020044856A KR20040011751A (en) 2002-07-30 2002-07-30 An organic acid salt of amlodipine
KR10-2002-0044856 2002-07-30
PCT/KR2003/001522 WO2004011432A1 (en) 2002-07-30 2003-07-30 Organic acid salt of amlodipine

Publications (1)

Publication Number Publication Date
AU2003247208A1 true AU2003247208A1 (en) 2004-02-16

Family

ID=31185754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003247208A Abandoned AU2003247208A1 (en) 2002-07-30 2003-07-30 Organic acid salt of amlodipine

Country Status (8)

Country Link
EP (1) EP1549616A4 (en)
JP (1) JP2005538103A (en)
KR (1) KR20040011751A (en)
CN (1) CN1678583A (en)
AU (1) AU2003247208A1 (en)
BR (1) BR0313076A (en)
MX (1) MXPA05001241A (en)
WO (1) WO2004011432A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100913791B1 (en) * 2006-07-21 2009-08-26 한미약품 주식회사 S---amlodipine camsylate or hydrate thereof and pharmaceutical composition containing same
KR100821688B1 (en) 2006-08-10 2008-04-11 (주)유케이케미팜 Separation method of enantiomer of Amlodipine racemate and process for preparing its hydrophilic drug
LT3150610T (en) 2010-02-12 2019-11-11 Pfizer Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
CN101972254B (en) * 2010-09-28 2012-05-30 石药集团欧意药业有限公司 Solid preparation of levamlodipine or pharmaceutically-acceptable salts thereof, and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
KR100452491B1 (en) * 2001-03-29 2004-10-12 한미약품 주식회사 A novel crystalline amlodipine camsylate and a preparing method thereof

Also Published As

Publication number Publication date
WO2004011432A1 (en) 2004-02-05
JP2005538103A (en) 2005-12-15
MXPA05001241A (en) 2005-06-08
EP1549616A1 (en) 2005-07-06
BR0313076A (en) 2005-06-28
KR20040011751A (en) 2004-02-11
EP1549616A4 (en) 2006-10-18
CN1678583A (en) 2005-10-05

Similar Documents

Publication Publication Date Title
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2003247656A1 (en) Oxidation of organic compounds
AU2003296419A1 (en) Pyrenyloxysulfonic acid fluorescent agents
AU2002314371A1 (en) Electrosynthesis of organic compounds
AU2003236991A1 (en) Representations of processes
AU2003287178A1 (en) Chemical compounds
AUPS005002A0 (en) Improvements relating to walling methods
AU2003277596A1 (en) Method of deuterization
AU2003291889A1 (en) Footing form
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2002365647A1 (en) Pyridyloxyalkanoic acid amide derivatives useful as fungicides
AU2003290661A1 (en) Chemical compounds
AU2003287912A1 (en) Dicarboxylic acid derivatives as ppar-agonists
AU2003289910A1 (en) Isophtalic acid derivatives
AU2003250858A1 (en) Use of organic compounds
AU2003253460A1 (en) Crystalline organic acid salt of amlodipine
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003284217A1 (en) Chemical compounds
AUPS096002A0 (en) Method of construction
AU2003247209A1 (en) Organic acid salt of amlodipine
AU2003247208A1 (en) Organic acid salt of amlodipine
AU2003247210A1 (en) Organic acid salt of amlodipine
AU2003256093A1 (en) Organic acid salt of amlodipine
AU2003255454A1 (en) Heterocyclylcarbonyl aminocyclopropane carboxylic acid derivatives
AU2003235429A1 (en) (2s)-2-ethylphenylpropionic acid derivative

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase